through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
Introduction Have you ever wondered how doctors can measure inflammation inside your airways without a biopsy or a blood test? There is a simple, non-invasive way: by analyzing your breath. When you breathe out, your breath contains tiny ...
Introduction: More Than Just a Cough Imagine trying to breathe through a narrow straw while running. Now, imagine feeling that way even when you are sitting still. For over 260 million people worldwide, this is the daily reality of living...
When you breathe, your lungs tell a story—one of resistance, reactance, and tiny vibrations deep within your airways. Traditionally, doctors asked patients to “blow hard and fast” into a spirometer. But what if the patie...
Please complete the form to contact our team